$61.98
+0.01
(+0.02%)▲
0.81%
Downside
Day's Volatility :3.2%
Upside
2.41%
59.49%
Downside
52 Weeks Volatility :61.98%
Upside
6.15%
Period | Radnet Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 28.04% | 6.5% | 0.0% |
6 Months | 66.32% | 7.1% | 0.0% |
1 Year | 87.73% | 9.8% | 0.0% |
3 Years | 77.67% | 14.2% | -20.2% |
Market Capitalization | 4.8B |
Book Value | $11.81 |
Earnings Per Share (EPS) | 0.37 |
PE Ratio | 175.81 |
PEG Ratio | 2.32 |
Wall Street Target Price | 64.5 |
Profit Margin | 1.28% |
Operating Margin TTM | 2.72% |
Return On Assets TTM | 2.35% |
Return On Equity TTM | 6.37% |
Revenue TTM | 1.7B |
Revenue Per Share TTM | 24.94 |
Quarterly Revenue Growth YOY | 10.5% |
Gross Profit TTM | 288.8M |
EBITDA | 230.8M |
Diluted Eps TTM | 0.37 |
Quarterly Earnings Growth YOY | 24.0 |
EPS Estimate Current Year | 0.6 |
EPS Estimate Next Year | 0.75 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.19 |
What analysts predicted
Upside of 4.07%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 975.1M | ↑ 5.74% |
Net Income | 32.2M | ↑ 60735.85% |
Net Profit Margin | 3.31% | ↑ 3.3% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↑ 18.36% |
Net Income | 23.4M | ↓ 27.3% |
Net Profit Margin | 2.03% | ↓ 1.28% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↓ 7.13% |
Net Income | -1.7M | ↓ 107.46% |
Net Profit Margin | -0.16% | ↓ 2.19% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 22.69% |
Net Income | 44.3M | ↓ 2633.96% |
Net Profit Margin | 3.37% | ↑ 3.53% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↑ 8.74% |
Net Income | 33.6M | ↓ 24.17% |
Net Profit Margin | 2.35% | ↓ 1.02% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.6B | ↑ 13.05% |
Net Income | 3.0M | ↓ 90.94% |
Net Profit Margin | 0.19% | ↓ 2.16% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 383.9M | ↑ 9.66% |
Net Income | 5.0M | ↓ 22.93% |
Net Profit Margin | 1.29% | ↓ 0.55% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 390.6M | ↑ 1.74% |
Net Income | -14.3M | ↓ 387.44% |
Net Profit Margin | -3.66% | ↓ 4.95% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 403.7M | ↑ 3.37% |
Net Income | 8.4M | ↓ 158.59% |
Net Profit Margin | 2.07% | ↑ 5.73% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 402.0M | ↓ 0.43% |
Net Income | 17.5M | ↑ 109.58% |
Net Profit Margin | 4.36% | ↑ 2.29% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 420.4M | ↑ 4.58% |
Net Income | -1.9M | ↓ 110.6% |
Net Profit Margin | -0.44% | ↓ 4.8% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 431.7M | ↑ 2.69% |
Net Income | -2.8M | ↑ 49.41% |
Net Profit Margin | -0.64% | ↓ 0.2% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.1B | ↑ 27.66% |
Total Liabilities | 909.1M | ↑ 13.77% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 48.34% |
Total Liabilities | 1.4B | ↑ 55.37% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.8B | ↑ 8.57% |
Total Liabilities | 1.5B | ↑ 8.2% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.1B | ↑ 15.21% |
Total Liabilities | 1.7B | ↑ 12.04% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 2.4B | ↑ 18.24% |
Total Liabilities | 1.9B | ↑ 13.44% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 2.9B | ↑ 18.6% |
Total Liabilities | 2.1B | ↑ 6.74% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.4B | ↑ 8.31% |
Total Liabilities | 1.9B | ↑ 8.59% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.4B | ↓ 0.82% |
Total Liabilities | 1.9B | ↓ 1.11% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.7B | ↑ 12.06% |
Total Liabilities | 1.9B | ↑ 1.21% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.7B | ↓ 0.64% |
Total Liabilities | 1.9B | ↓ 2.7% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.9B | ↑ 7.39% |
Total Liabilities | 2.1B | ↑ 9.59% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 3.0B | ↑ 2.87% |
Total Liabilities | 1.9B | ↓ 8.73% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 116.8M | ↓ 17.31% |
Investing Cash Flow | -146.7M | ↑ 85.01% |
Financing Cash Flow | -10.9M | ↓ 66.29% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 104.3M | ↓ 10.65% |
Investing Cash Flow | -99.5M | ↓ 32.22% |
Financing Cash Flow | 25.0M | ↓ 329.56% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 233.8M | ↑ 124.07% |
Investing Cash Flow | -126.2M | ↑ 26.92% |
Financing Cash Flow | -45.6M | ↓ 282.6% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 149.5M | ↓ 36.05% |
Investing Cash Flow | -221.5M | ↑ 75.46% |
Financing Cash Flow | 104.7M | ↓ 329.74% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 146.4M | ↓ 2.06% |
Investing Cash Flow | -246.9M | ↑ 11.48% |
Financing Cash Flow | 93.6M | ↓ 10.53% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 53.6M | ↑ 98.5% |
Investing Cash Flow | -123.9M | ↑ 357.88% |
Financing Cash Flow | 103.6M | ↓ 3226.62% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 32.6M | ↓ 39.2% |
Investing Cash Flow | -65.6M | ↓ 47.09% |
Financing Cash Flow | -3.8M | ↓ 103.69% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 68.1M | ↑ 108.72% |
Investing Cash Flow | -40.4M | ↓ 38.44% |
Financing Cash Flow | 238.1M | ↓ 6331.95% |
Sell
Neutral
Buy
Radnet Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Radnet Inc | 6.62% | 66.32% | 87.73% | 77.67% | 320.42% |
![]() Idexx Laboratories, Inc. | -3.67% | -10.34% | -15.37% | -31.35% | 65.77% |
![]() Agilent Technologies Inc. | 1.42% | 3.05% | 5.07% | -10.16% | 94.22% |
![]() Thermo Fisher Scientific, Inc. | 6.51% | 8.62% | 3.5% | 12.36% | 106.99% |
![]() Danaher Corp. | 6.51% | 15.92% | 1.97% | -6.92% | 89.83% |
![]() Iqvia Holdings Inc. | 10.0% | 7.5% | 0.14% | -6.07% | 45.29% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Radnet Inc | 175.81 | 175.81 | 2.32 | 0.6 | 0.06 | 0.02 | NA | 11.81 |
![]() Idexx Laboratories, Inc. | 45.67 | 45.67 | 4.75 | 11.06 | 0.72 | 0.23 | NA | 18.93 |
![]() Agilent Technologies Inc. | 31.63 | 31.63 | 2.7 | 5.2 | 0.21 | 0.08 | 0.01 | 21.31 |
![]() Thermo Fisher Scientific, Inc. | 35.72 | 35.72 | 2.81 | 21.71 | 0.14 | 0.05 | 0.0 | 120.87 |
![]() Danaher Corp. | 48.76 | 48.76 | 3.13 | 6.99 | 0.08 | 0.04 | 0.0 | 68.92 |
![]() Iqvia Holdings Inc. | 30.13 | 30.13 | 1.33 | 11.19 | 0.23 | 0.05 | NA | 36.83 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Radnet Inc | Buy | $4.8B | 320.42% | 175.81 | 1.28% |
![]() Idexx Laboratories, Inc. | Buy | $38.8B | 65.77% | 45.67 | 23.26% |
![]() Agilent Technologies Inc. | Buy | $38.9B | 94.22% | 31.63 | 18.84% |
![]() Thermo Fisher Scientific, Inc. | Buy | $219.4B | 106.99% | 35.72 | 14.2% |
![]() Danaher Corp. | Buy | $191.9B | 89.83% | 48.76 | 17.83% |
![]() Iqvia Holdings Inc. | Buy | $42.3B | 45.29% | 30.13 | 9.39% |
Insights on Radnet Inc
Revenue is up for the last 3 quarters, 401.96M → 431.70M (in $), with an average increase of 3.5% per quarter
Netprofit is down for the last 3 quarters, 17.54M → -2.77M (in $), with an average decrease of 80.0% per quarter
BlackRock Inc
Vanguard Group Inc
Beck, Mack & Oliver LLC
State Street Corporation
Jb Capital Partners LP
Dimensional Fund Advisors, Inc.
radnet, inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the united states based on the number of locations and annual imaging revenue. radnet has a network of 340+ owned and/or operated outpatient imaging centers. radnet's core markets include california, delaware, maryland, new jersey, and new york. together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, radnet has a total of approximately 7,300 employees.
Organization | Radnet Inc |
Employees | 9700 |
CEO | Dr. Howard G. Berger M.D. |
Industry | Health Services |
Outfront Media Inc.
$61.98
+0.02%
Blackrock Short Duration Bond Etf
$61.98
+0.02%
Moog Inc
$61.98
+0.02%
Edgio Inc.
$61.98
+0.02%
Invesco S&p 500 Momentum Etf
$61.98
+0.02%
Silicon Laboratories Inc
$61.98
+0.02%
Helmerich & Payne, Inc.
$61.98
+0.02%
Crane Nxt Co
$61.98
+0.02%
Liberty Global Plc - Class C Shares
$61.98
+0.02%